Novo Nordisk is planning a new Phase III trial for CagriSema, the company’s next-generation obesity drug touted as a potential successor to Wegovy (semaglutide), as the company aims to quell ...

Novo Nordisk shares rose after the drugmaker reported strong sales growth for its blockbuster obesity and diabetes drugs and issued a forecast for full-year 2025 results that topped analysts ...

Speaking at the reopening of the Thailand office of Novo Nordisk, a leading global healthcare company, Mr Annan highlighted how the company is driven not only by pharmaceutical excellence but also ...

Novo Nordisk and Eli Lilly have asked the federal government to list their blockbuster weight-loss drugs on the Pharmaceutical Benefits Scheme, arguing funding the treatment will reduce a costly ...

"Brand Karigor- Modern Branding Strategy," a career-based book by young writer and journalist Sajjadur Rahman Shuvo, has been published at the Amar Ekushey Book Fair 2025. The book was published by ...

India on Thursday strongly condemned the destruction of Bangladesh's founding father Sheikh Mujibur Rahman's residence in Dhaka. The incident occurred on February 5, when thousands of protestors ...

Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this. On rare occasions, our expert team of analysts issues a “Double Down” stock ...

Financial giants have made a conspicuous bearish move on Novo Nordisk. Our analysis of options history for Novo Nordisk (NYSE:NVO) revealed 18 unusual trades. Delving into the details, we found 33 ...

Protesters set fire to the Dhanmondi-32 residence of Bangabandhu Sheikh Mujibur Rahman, father of the ousted PM Sheikh Hasina, in Dhaka, Bangladesh February 5, 2025. (Photo source: Wikimedia ...

The house held great significance within Bangladesh’s independence movement, and many global leaders met with Rahman in this house until his assassination. Protesters view Rahman’s house and ...

Denmark's Novo Nordisk has agreed to pay $70 million to license rights to a drug developed by Ventus Therapeutics with potential in non-alcoholic steatohepatitis (NASH) and several other diseases ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other stocks. Ken Fisher is the founder and executive chairman of Fisher Asset Management ...